Health & Fitness
MelroseWakefield Hospital performs first drug-coated balloon procedure
New Drug-coated balloons effectively treat in-stent restenosis

The MelroseWakefield Hospital Cardiovascular Center completed another important "first" last week, when they used a drug-coated balloon while treating a patient with coronary artery disease. Dr. Laurence Conway, Chief of Cardiology, performed the procedure.
Manufactured by Boston Scientific, the AGENT™ Drug-Coated Balloon (DCB) is the first FDA-approved drug-coated coronary balloon in the U.S. for the treatment of coronary in-stent restenosis.
In-stent restenosis (ISR) occurs when a previously stented artery becomes re-narrowed or blocked by scar tissue or plaque. transfers a therapeutic dose of paclitaxel to the coronary artery wall to help prevent ISR reoccurrence.